Tag: CX 2021
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Treating venous stenosis: Experts agree re-evaluation of AV graft surveillance is...
In its current form, postprocedural surveillance of arteriovenous grafts (AVGs) used to treat venous stenosis is “little more than supervised neglect”, and should be...
High-flow fistulas remain divisive, with uncertainty over reduction and outcomes
Discussions at this year’s Charing Cross (CX) 2021 Digital Edition (19–22 April, online) indicated that high-flow arteriovenous (AV) fistulas remain one of the more...
Two-year IN.PACT AV Access results presented at CX 2021
Medtronic recently announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually...
Debate over flow reduction in asymptomatic high-flow fistulas leaves CX 2021...
Consensus is split over the need for flow reduction in high-flow fistulas to avoid cardiac complications in dialysis patients, polling taken during the Charing...